BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11937267)

  • 1. Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors.
    Bhatia R; Williams AD; Munthe HA
    Exp Hematol; 2002 Apr; 30(4):324-32. PubMed ID: 11937267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
    Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML
    Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of homing properties of primitive progenitor cells generated by ex vivo expansion.
    Foguenne J; Huygen S; Greimers R; Beguin Y; Gothot A
    Haematologica; 2005 Apr; 90(4):445-51. PubMed ID: 15820938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation.
    Lundell BI; McCarthy JB; Kovach NL; Verfaillie CM
    Leukemia; 1997 Jun; 11(6):822-9. PubMed ID: 9177435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.
    Bhatia R; McCarthy JB; Verfaillie CM
    Blood; 1996 May; 87(9):3883-91. PubMed ID: 8611716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal growth factor modulation of beta1-integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors.
    Bhatia R; Munthe HA; Forman SJ
    Br J Haematol; 2001 Dec; 115(4):845-53. PubMed ID: 11843818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
    Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM
    Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors.
    Bhatia R; Munthe HA; Verfaillie CM
    Leukemia; 1998 Nov; 12(11):1708-17. PubMed ID: 9823945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation-dependent alpha5beta1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells.
    Lundell BI; McCarthy JB; Kovach NL; Verfaillie CM
    Blood; 1996 Mar; 87(6):2450-8. PubMed ID: 8630410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
    Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
    Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals.
    Bendall LJ; Makrynikola V; Hutchinson A; Bianchi AC; Bradstock KF; Gottlieb DJ
    Leukemia; 1998 Sep; 12(9):1375-82. PubMed ID: 9737685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors.
    Kasper B; Fruehauf S; Schiedlmeier B; Buchdunger E; Ho AD; Zeller WJ
    Cancer Chemother Pharmacol; 1999; 44(5):433-8. PubMed ID: 10501919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin.
    Verfaillie CM; McCarthy JB; McGlave PB
    J Exp Med; 1991 Sep; 174(3):693-703. PubMed ID: 1875168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin engagement-induced inhibition of human myelopoiesis is mediated by proline-rich tyrosine kinase 2 gene products.
    Dylla SJ; Deyle DR; Theunissen K; Padurean AM; Verfaillie CM
    Exp Hematol; 2004 Apr; 32(4):365-74. PubMed ID: 15050747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation.
    Zweegman S; Veenhof MA; Huijgens PC; Schuurhuis GJ; Dräger AM
    Exp Hematol; 2000 Apr; 28(4):401-10. PubMed ID: 10781898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors.
    Bhatia R; Verfaillie CM
    Blood; 1998 May; 91(9):3414-22. PubMed ID: 9558400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia.
    Petzer AL; Eaves CJ; Barnett MJ; Eaves AC
    Blood; 1997 Jul; 90(1):64-9. PubMed ID: 9207439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.
    Moore S; Haylock DN; Lévesque JP; McDiarmid LA; Samels LM; To LB; Simmons PJ; Hughes TP
    Blood; 1998 Oct; 92(7):2461-70. PubMed ID: 9746786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors.
    Bhatia R; Munthe HA; Verfaillie CM
    Exp Hematol; 1999 Sep; 27(9):1384-96. PubMed ID: 10480429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.